Chart pattern: Double Bottom (weekly)
▲ Broken out
Broke on Oct 09, 2026 · measured target $1,049.02 (-1%). Details →
Nov 4, 4:06 PM ET
McKesson Corporation reported preliminary financial results for the second quarter ended September 30, 2026, delivering consolidated revenues of $111.0 billion and diluted earnings per share of $10.44. Driven by operational strength across core segments, management raised its fiscal 2027 adjusted earnings per diluted share guidance range to $45.60 to $46.40. These results highlight solid performance that supports strategic capital deployment and shareholder value creation.
- Consolidated revenues reached $111.0 billion for the quarter ended September 30, 2026, representing an 8% increase year-over-year.
- Adjusted earnings per diluted share rose 18% to $11.68 compared to $9.86 in the prior year period.
- The full-year fiscal 2027 adjusted EPS guidance was raised to a range of $45.60 to $46.40.
- The company generated $3.1 billion in cash flow from operations and $2.9 billion of free cash flow during the second quarter.
Read the filing on SEC.gov ↗
Oct 6, 8:03 AM ET
McKesson and CD&R agreed to acquire Option Care Health for $32.05 per share, a total enterprise value of approximately $5.8 billion. McKesson will invest approximately $1.4 billion for a minority stake of approximately 49%, while CD&R will hold approximately 51%, and the filing describes a framework for McKesson to later acquire CD&R's interest.
- Price of $32.05 per share, a premium of approximately 37% to Option Care Health's October 5, 2026 closing price
- McKesson to invest approximately $1.4 billion for a minority stake of approximately 49%; CD&R to hold approximately 51%
- Expected to close in the first half of calendar 2027, subject to Option Care Health stockholder approval and regulatory approvals
Read the filing on SEC.gov ↗
Aug 28, 4:05 PM ET
McKesson disclosed that it discovered a cybersecurity incident affecting its information systems on August 25, 2026, and that its investigation is in early stages. The company said it has not determined the incident is material or that it has had, or is reasonably likely to have, a material impact on its financial condition or results of operations.
- Incident discovered August 25, 2026; investigation described as in early stages
- McKesson has not determined the incident is material as of the filing date
- Updates are posted at www.mckesson.com/cybersecurity
- Filing dated August 28, 2026, signed by Chief Legal Officer Michele Lau
Read the filing on SEC.gov ↗
Aug 5, 4:06 PM ET
McKesson reported first-quarter fiscal 2027 revenue of $105.4 billion, up 8%, and adjusted earnings per diluted share of $9.93, up 20%, and raised its full-year adjusted EPS guidance to $44.20 to $45.00. GAAP EPS fell 18% to $5.15, mainly because of a $293 million redemption value adjustment tied to the Medical-Surgical Solutions minority stake sold to Apollo Funds, so shareholders face a mixed picture between the higher adjusted results and the lower GAAP profit.
- Revenue of $105.4 billion rose 8% from $97.8 billion a year earlier.
- GAAP EPS was $5.15 versus $6.25, a decrease of $1.10, primarily due to a $293 million redemption value adjustment.
- Adjusted EPS was $9.93 versus $8.26, an increase of 20%.
- Full-year fiscal 2027 adjusted EPS guidance was raised to $44.20 to $45.00 from $43.80 to $44.60; the quarterly dividend was raised 15% to $0.94 per share.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.